Burning Rock Biotech Ltd. (BNR)
9.80
-0.52
(-5.04%)
USD |
NASDAQ |
Aug 25, 16:00
Burning Rock Biotech Net Income (Quarterly) : -2.523M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.523M |
| December 31, 2025 | -2.17M |
| September 30, 2025 | -2.341M |
| June 30, 2025 | -1.341M |
| March 31, 2025 | -1.855M |
| December 31, 2024 | -11.31M |
| September 30, 2024 | -4.987M |
| June 30, 2024 | -14.92M |
| March 31, 2024 | -16.91M |
| December 31, 2023 | -22.44M |
| September 30, 2023 | -24.15M |
| June 30, 2023 | -18.70M |
| March 31, 2023 | -27.08M |
| December 31, 2022 | -30.38M |
| September 30, 2022 | -33.78M |
| Date | Value |
|---|---|
| June 30, 2022 | -39.64M |
| March 31, 2022 | -41.17M |
| December 31, 2021 | -39.28M |
| September 30, 2021 | -26.35M |
| June 30, 2021 | -31.54M |
| March 31, 2021 | -26.46M |
| December 31, 2020 | -23.61M |
| September 30, 2020 | -18.38M |
| June 30, 2020 | -10.02M |
| March 31, 2020 | -7.533M |
| December 31, 2019 | -13.50M |
| September 30, 2019 | -4.585M |
| June 30, 2019 | -3.814M |
| March 31, 2019 | -2.352M |
| December 31, 2018 | -7.798M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -43.20M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 110.64M |
| Natera, Inc. | -66.97M |
| Exagen, Inc. | -3.196M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.59M |
| Total Expenses (Quarterly) | 18.11M |
| EPS Diluted (Quarterly) | -0.2399 |
| Enterprise Value | 28.51M |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -16.19% |
| Earnings Yield | -8.04% |
| Normalized Earnings Yield | -8.041 |